NCT07433556

Safety, Tolerability, Pharmacokinetic and Pharmacodynamic of IY-828026 in Healthy Volunteers

A Randomized, Double-blinded, Partial-open, Placebo/Active-controlled, Single/Multiple Dosing, Dose Escalation Phase 1 Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Characteristics of IY-828026 in Healthy Adult Volunteers

• Status: Recruiting
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 86 (estimated)
• Sponsor: Il-Yang Pharm. Co., Ltd. · Industry
• Sex: All
• Age: 19 Years – 50 Years
• Healthy volunteers: Accepted

Summary

A randomized, double-blinded, partial-open, placebo/active-controlled, single/multiple dosing, dose escalation phase 1 clinical trial to evaluate the safety, tolerability, pharmacokinetic, and pharmacodynamic characteristics of IY-828026 in healthy adult volunteers

Conditions

• Healhty

Interventions

Type	Name	Description
DRUG	IY-828026	IY-828026
DRUG	Placebo	Placebo comparator
DRUG	IY-828026A	Active comparator
DRUG	IY-828026B	Active comparator

Timeline

• Start date: 2026-03-23
• Primary completion: 2027-03-01
• Completion: 2027-06-01
• First posted: 2026-02-25
• Last updated: 2026-03-27

Locations

1 site across 1 country: South Korea